{
  "trial_id": "NCT03299322",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "Patient diagnosed with chronic persistent asthma",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Annual uncontrollable time \u2265 3 months",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "Patients who have given written informed consent",
      "label": "met",
      "evidence": "quote"
    }
  ],
  "exclusion": [
    {
      "criterion": "History of upper upper/lower respiratory infection in the previous 1 months",
      "label": "not_met",
      "evidence": "none"
    },
    {
      "criterion": "History of long-term controller medication use for asthma (oral corticosteroid or intravenous corticosteroids therapy) within the preceding 1 months",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "History of antibiotic use in the previous 1 months",
      "label": "not_met",
      "evidence": "none"
    }
  ],
  "notes": "Patient has a history of asthma and is currently using ICS and fluticasone. However, he has recently doubled his oral corticosteroids, which may be a concern for eligibility.",
  "_meta": {
    "topic_id": "23",
    "trial_id": "NCT03299322",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}